Home » Topics » BioWorld Science

BioWorld Science
RSS

ProMIS identifies novel antagonists against RACK1 for neurodegenerative diseases

May 6, 2020

Genzyme initiates phase III study of venglustat in late-onset GM2 gangliosidosis

May 6, 2020

Enrollment on track in phase IIb GALACTIC-1 study of GB-0139 in IPF

May 6, 2020

FDA clears Kiadis to begin phase II study of K-NK-002 produced with PM21

May 6, 2020

Novel animal model of cardiac reperfusion injury

May 6, 2020

Veru reports positive phase Ib data for VERU-111

May 6, 2020

ORIC Pharmaceuticals' OP-5244 reverses immunosuppression in vivo

May 6, 2020

Positive topline data from the UNITY-CLL phase III study

May 6, 2020

Heptares Therapeutics presents new histamine H4 receptor antagonists

May 6, 2020

Medshine Discovery identifies TLR8 agonists for HBV infection

May 6, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...